What is BINV.ST's gross margin?

BioInvent (BINV.ST) has a gross margin of 100% and a net margin of -964%.

What is BINV.ST's P/E ratio?

Track BioInvent (BINV.ST) P/E ratio, ROE, and valuation metrics over time.

Where can I see BINV.ST's full financials?

See BioInvent (BINV.ST) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

BioInvent (BINV.ST) Financials — Revenue, Earnings, Cash Flow

Also trades as: 0H22.L (LSE) · $vol 0M · BOVNF (OTC) · $vol 0M

kr 22.90 ($2.27)

+0.40 (+1.78%)

Weekly Expected Move ±5.8%

kr 20 kr 22 kr 23 kr 24 kr 26

STO · Healthcare · Biotechnology · Tech Score Sell · Power 27 · kr 1.5B mcap · 48M float · 0.285% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

kr 33M

Revenue

-87.2% YoY

kr -497M

Net Income

-70.3% YoY

kr -444M

Free Cash Flow

-73.6% YoY

100.0%

Gross Margin

-980.4%

Op. Margin

-964.0%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-88.1%

ROA-74.2%

ROIC19974.7%

Valuation

P/E-3.0

P/B4.7

EV/EBITDA-2.7

Leverage

Debt/Equity0.07

Current Ratio4.06

Interest Cov.0.0x

Quality Scores

Piotroski F1/9

Altman Z6.12

Beneish M-0.79